Wed.Aug 21, 2024

article thumbnail

Meat Consumption Linked with Higher Risk of Developing Type 2 Diabetes

Drug Topics

Increased incidence of typed 2 diabetes was associated with higher consumption of processed meat, unprocessed red meat, and poultry.

199
199
article thumbnail

Opinion: Doing more cancer screening won’t reduce Black-white health disparities

STAT

For years, Black Americans have been more likely to die of cancer than white Americans. There is a widespread belief that cancer screening — tests to detect hidden cancer — can reduce this Black-white disparity. While it is important to be attentive to racial disparities in health and health care, the belief in screening is misguided. More cancer screening primarily serves the interests of the health care system, not those of Black Americans.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Q&A: Discussing the Dangers of Buying GLP-1s From Online Pharmacies

Drug Topics

Timothy Mackey, MAS, PhD, discusses a study that sought to determine the risk of sourcing semaglutide from online platforms.

163
163
article thumbnail

Alzheimer’s drug may raise the risk of brain bleed in patients with Down syndrome

STAT

A year ago, after much fanfare and controversy , the Food and Drug Administration approved Eisai and Biogen’s lecanemab, an anti-amyloid drug that moderately slowed cognitive decline in patients with Alzheimer’s disease. But doctors have been hesitant to prescribe the drug and its pharmacological cousin, Eli Lilly’s donanemab, for people with Down syndrome because of a lack of safety data.

FDA 137
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Tirzepatide Demonstrates 94% Diabetes Reduction, 22% Weight Loss in SURMOUNT-1 Study

Drug Topics

A detailed report of study findings will be published in a peer-reviewed journal and presented at ObesityWeek 2024.

163
163
article thumbnail

Merck Plans to Acquire Investigational Bispecific Antibody from Curon Biopharmaceutical in $1.3 Billion Deal

BioPharm

Under a deal worth potentially up to $1.3 billion, Merck, known as MSD outside of the United States and Canada, will acquire CN201, a next-generation bispecific antibody, from Curon Biopharmaceutical.

122
122

More Trending

article thumbnail

Ask NAVLIN: The AI chatbot innovation driving a better global customer experience

pharmaphorum

Demonstrating EVERSANA's dedication to innovation, a novel artificial intelligence technology is set to enhance the NAVLIN experience for both current and prospective customers.

120
120
article thumbnail

Majority of Savings from CMS Price Negotiations Comes From 3 Drugs

Drug Topics

Research experts at the Brookings Institution in Washington, D.C., analyzed the savings estimates provided by CMS for its drug price negotiations and compared them with the institution’s own estimates.

112
112
article thumbnail

Overturning Chevron Deference Could Lead to Confusion, Chaos Across Pharmaceutical Industry

Pharmacy Times

The decision by the Supreme Court has the potential to upend the power of regulatory agencies to shape the health care landscape of the country.

129
129
article thumbnail

Biogen sued for alleged PBM kickbacks scheme to boost Tecfidera in wake of generics

Fierce Pharma

As Biogen’s relentless patent defense for blockbuster multiple sclerosis med Tecfidera came up short in the U.S., the company separately worked to fend off competition through an anticompetitive ki | A multi-employer health benefit plan in Illinois accused the drugmaker of scheming with pharmacy benefit managers to keep its Tecfidera in a more favorable spot on their formularies.

116
116
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Proposed Bill Requires States to Use Opioid Settlement Funds to Address the Opioid Epidemic

Pharmacy Times

The money could be used for prevention and treatment services, health care practitioner training, or other ways to stem the epidemic.

131
131
article thumbnail

CMS closes thousands of No Surprises Act complaints, directs $4M in relief

Fierce Healthcare

The Centers for Medicare & Medicaid Services (CMS) issued a new report Tuesday detailing total complaints related to the No Surprises Act and Affordable Care Act compliance. | A new CMS report outlines the types of No Surprises Act complaints resolved by the federal agency since June 30.

126
126
article thumbnail

Study reignites debate on GLP-1 drugs and suicide risk

pharmaphorum

Debate over the safety of GLP-1 drugs resurfaces after study finds 'disproportional' risk of suicidal thinking adverse event reports with Novo Nordisk's semaglutide

109
109
article thumbnail

Methotrexate and Bactrim – Important Drug Interaction

Med Ed 101

EJ is a 54-year-old female with a history of rheumatoid arthritis. She has been on methotrexate (with folic acid supplementation) for years with relatively few RA flares over the last 10 years. She was recently diagnosed with a urinary tract infection and was prescribed sulfamethoxazole/trimethoprim (Bactrim). What concerns should we have regarding the methotrexate and […] The post Methotrexate and Bactrim – Important Drug Interaction appeared first on Med Ed 101.

111
111
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Medicare plans accuse Teva of covering copays for patients

pharmaphorum

A class action suit has been filed in the US against Teva, claiming that the company illegally subsidised the copays for patients prescribed its multiple sclerosis therapy Copaxone to boost its sales.The suit filed on behalf of Medicare Advantage coverage providers accuses the company of "funnelling hundreds of millions of dollars" to Copaxone (glatiramer acetate) patients through third-party foundations and companies.

109
109
article thumbnail

Understanding Pharmacy Deserts: How Can We Impact This Growing Trend?

Pharmacy Times

When a community loses a pharmacy, it loses a trusted health care provider. Understanding the root causes of these closures—and what we can do about it—can drive change.

139
139
article thumbnail

J&J's Rybrevant okay challenges Tagrisso in first-line NSCLC

pharmaphorum

J&J's Rybrevant/Lazcluze combination is cleared by FDA for first-line EGFR+ NSCLC, giving AstraZeneca's top-seller Tagrisso its first direct competition

FDA 108
article thumbnail

Federal judge blocks FTC's nationwide noncompete ban

Fierce Healthcare

A Texas federal judge has struck down the Federal Trade Commission’s rule broadly banning employers’ noncompete agreements 15 days before it was set to go into effect nationwide. | U.S. District Judge Ada Brown ruled that the FTC exceeded its statutory authority and failed to present sufficient evidence for its sweeping ban. Mixed rulings among other district courts and comments from a regulator spokesperson suggest an appeal is likely.

123
123
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Sustainability is increasingly important in pharma, but several hurdles are slowing the effort: survey

Fierce Pharma

A survey of 800 biopharma executives shows that sustainability is an increasingly important priority but that companies are struggling to achieve it.

113
113
article thumbnail

STAT+: Pharmalittle: We’re reading about obesity drugs and suicidal thoughts, a FDA official’s conflicts, and more

STAT

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is now upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not particularly appealing. So what better way to make the time fly than to keep busy.

FDA 105
article thumbnail

Can you take biotin and Synthroid together?

The Checkup by Singlecare

Many people taking Synthroid (levothyroxine) for thyroid problems might also take biotin to supplement their health or to manage Synthroid side effects like hair loss. While biotin is known for its benefits for hair and nails, there are potential interactions to consider if you’re taking thyroid medication. Biotin can interfere with thyroid function tests, causing misleading results and possibly affecting your treatment plan.

Dosage 98
article thumbnail

Despite trial scare, Travere’s Filspari gains full FDA nod in kidney disease showdown with Novartis

Fierce Pharma

A year after missing on a trial endpoint, Travere Therapeutics can breathe a sigh a relief. | A year after missing on a trial endpoint, Travere Therapeutics can breathe a sigh a relief. The FDA has converted Filspari’s conditional nod in the kidney disease IgAN into a full approval but left a liver toxicity monitoring requirement in place.

FDA 97
article thumbnail

Study: Biosimilar Etanercept Shows Equivalence With Reference Product for Rheumatoid Arthritis

Pharmacy Times

Biosimilar etanercept (Sunshine Guojian Pharmaceutical) showed similar therapeutic outcomes compared with etanercept (Enbrel; Amgen) specific to rheumatoid arthritis.

132
132
article thumbnail

How can digital technologies help pharma meet the changing needs of HCPs and patients?

pharmaphorum

Digital technologies play a crucial role in helping the pharmaceutical industry meet the changing needs of healthcare providers (HCPs) and patients. Learn how digital innovations are transforming healthcare delivery and improving patient outcomes in this comprehensive guide.

94
article thumbnail

NACDS President: Technological Innovation, Policy Initiatives Key Focuses for Future

Pharmacy Times

President of NACDS, Steve Anderson, discusses how the events at Total Store Expo reflect on the association's goals of innovation and a focus on public policy.

134
134
article thumbnail

Physician Shortage Provides Opportunity for Pharmacists to Step Up

Drug Topics

However, reimbursement for these services for pharmacists remains a crucial issue.

112
112
article thumbnail

Astellas employee held in China indicted by China’s prosecutors: Reuters

Fierce Pharma

More than a year after detaining an employee of Astellas for suspected spying, Chinese authorities have indicted the Japanese expat,

102
102
article thumbnail

Amneal Pharmaceuticals Receives FDA Approval for Propofol Injectable Emulsion Single-Dose Vials

Drug Topics

FDA approval of Amneal Pharmaceuticals' propofol injectable emulsion single-dose vials aims to address the drug’s history of chronic supply issues.

FDA 86
article thumbnail

Amgen’s Otezla launched for paediatric plaque psoriasis in US

Pharmaceutical Technology

Amgen has announced the availability of Otezla (apremilast) in the US for paediatric patients with moderate to severe plaque psoriasis.

98
article thumbnail

Aadi lays off 80% of R&D workforce as Fyarro heads to phase 2 solid tumor fail

Fierce Pharma

Aadi Bioscience’s Fyarro is on track to fail a phase 2 solid tumor trial, leading the biotech to halt the study and lay off 80% of its R&D workforce.

92
article thumbnail

NMPA approves AstraZeneca’s Fasenra for severe asthma

Pharmaceutical Technology

The China NMPA approved AstraZeneca's Fasenra for individuals aged 12 years and older with severe eosinophilic asthma (SEA).

98
article thumbnail

Tackling the Prior Authorization Problem with Innovative Technologies

Fierce Healthcare

By: Christie Callahan, Chief Operating Officer, Arrive Health | Tackling the Prior Authorization Problem with Innovative Technologies

107
107
article thumbnail

Emergent BioSolutions finalises manufacturing site sale to Bora Pharmaceuticals

Pharmaceutical Technology

The deal, valued at approximately $30m, contributes to Emergent’s financial recovery plan amid its dramatic post-Covid decline.

98